Moon Surgical Appoints Chris Toth as Independent Board Member Ahead of Commercial Acceleration [Yahoo! Finance]
Baxter International Inc. (BAX)
Last baxter international inc. earnings: 4/30 07:15 am
Check Earnings Report
US:NYSE Investor Relations:
investor.baxter.com
Company Research
Source: Yahoo! Finance
of Chris Toth as an independent member of its Board of Directors. With over 20 years of experience in scaling and managing commercial operations, Mr. Toth brings extensive expertise in commercial acceleration. The Maestro System by Moon Surgical Chris Toth is currently Executive Vice President and Group President of Baxter International, Inc.'s Kidney Care segment, which will be named Vantive upon completion of its pending sale to Carlyle by Baxter . Mr. Toth is the named CEO of Vantive. Prior to his current role, Toth was the CEO of Varian, a Siemens Healthineers company, where he spent 20 years in a variety of leadership roles, including President of Global Commercial and Field Operations. "The appointment of Chris to our board is a transformational moment for Moon Surgical," said Anne Osdoit, CEO of Moon Surgical and Partner at Sofinnova Partners. "Chris brings unparalleled expertise in scaling commercial operations globally. His leadership, operational insights and vision wi
Show less
Read more
Impact Snapshot
Event Time:
BAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAX alerts
High impacting Baxter International Inc. news events
Weekly update
A roundup of the hottest topics
BAX
News
- Peritoneal Dialysis Market Research 2024-2034: Growing Prevalence of Chronic Diseases Underscores Need for Dialysis Innovations [Yahoo! Finance]Yahoo! Finance
- Baxter to Present at 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- The Global Market for Motion Sickness Treatment, 2024-2030: Increasing Preference for OTC Solutions Strengthens Business Case [Yahoo! Finance]Yahoo! Finance
- Baxter International Inc. (NYSE: BAX) had its price target lowered by analysts at Citigroup Inc. from $37.00 to $35.00. They now have a "neutral" rating on the stock.MarketBeat
- Baxter Announces Continued Growth of Pharmaceuticals Portfolio With Five Injectable Product Launches in the U.S. [Yahoo! Finance]Yahoo! Finance
BAX
Earnings
- 11/8/24 - Miss
BAX
Sec Filings
- 12/17/24 - Form 4
- 12/4/24 - Form 4
- 12/4/24 - Form 4
- BAX's page on the SEC website